Table 1.
Baseline characteristics of LUAD patients in TCGA
| All (n = 522) | Alive (n = 334) | Dead (n = 188) | Poverall | |
|---|---|---|---|---|
| Age, years | 0.678 | |||
| > 65, n (%) | 262 (50.2%) | 163 (48.8%) | 99 (52.7%) | |
| ≤ 65, n (%) | 241 (46.2%) | 159 (47.6%) | 82 (43.6%) | |
| Unknown, n (%) | 19 (3.64%) | 12 (3.59%) | 7 (3.72%) | |
| Gender | 0.668 | |||
| Female, n (%) | 280 (53.6%) | 182 (54.5%) | 98 (52.1%) | |
| Male, n (%) | 242 (46.4%) | 152 (45.5%) | 90 (47.9%) | |
| Stage | < 0.001 | |||
| Stages I–II, n (%) | 403 (77.2%) | 280 (83.8%) | 123 (65.4%) | |
| Stages III–IV, n (%) | 111 (21.3%) | 48 (14.4%) | 63 (33.5%) | |
| Unknown, n (%) | 8 (1.53%) | 6 (1.80%) | 2 (1.06%) | |
| T | 0.005 | |||
| T1–2, n (%) | 453 (86.8%) | 301 (90.1%) | 152 (80.9%) | |
| T3–4, n (%) | 66 (12.6%) | 32 (9.58%) | 34 (18.1%) | |
| Unknown, n (%) | 3 (0.57%) | 1 (0.30%) | 2 (1.06%) | |
| N | < 0.001 | |||
| N0, n (%) | 335 (64.2%) | 245 (73.4%) | 90 (47.9%) | |
| N1-3, n (%) | 175 (33.5%) | 81 (24.3%) | 94 (50.0%) | |
| Unknown, n (%) | 12 (2.30%) | 8 (2.40%) | 4 (2.13%) | |
| M | 0.003 | |||
| M0, n (%) | 353 (67.6%) | 219 (65.6%) | 134 (71.3%) | |
| M1, n (%) | 25 (4.79%) | 10 (2.99%) | 15 (7.98%) | |
| Unknown, n (%) | 144 (27.6%) | 105 (31.4%) | 39 (20.7%) |
LUAD lung adenocarcinoma, TCGA The Cancer Genome Atlas